Skip to content

AMP WellBeing Intervention trial

Exploratory randomised controlled trial of a wellbeing intervention for under-served groups

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN68572159
Enrollment
100
Registered
2013-02-25
Start date
2010-09-20
Completion date
Unknown
Last updated
2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and/or depression Mental and Behavioural Disorders Anxiety disorder, unspecified

Interventions

One third of participants were randomised to receive treatment as usual, i.e. no clinical intervention from the research team. Two thirds of participants were randomised to receive the wellbeing inte
group sessions with other participants
or direction (signposting) to appropriate public or third sector services in their locality.

Sponsors

University of Liverpool (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female aged 50 and over for Croxteth and Wythenshawe participants 2. Aged 18 and over for Picton and Longsight participants 3. Somali heritage in Picton and South Asian (Pakistani or Bangladeshi) in Longsight; registered with one of the 16 primary care practices working with the AMP Development Partnership 4. Scoring 10 or more on the Patient Health Questionnaire 9 (PHQ)-9 and/or the Generalized Anxiety Disorder 7 (GAD-7)

Exclusion criteria

Exclusion criteria: 1. Currently deemed to be at significant risk to themselves or others 2. Significant learning disabilities and cognitive impairment

Design outcomes

Primary

MeasureTime frame
CORE-OM, a 34-item self report scale designed to measure global distress, including subjective well being, life/social functioning and risk measured at baseline and 20 weeks

Secondary

MeasureTime frame
1. PHQ-9 for depression 2. GAD-7 for anxiety 3. The Work and Social Adjustment Scale 4. The EQ-5D for quality of life Measured at baseline and 20 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 19, 2026